Pardeep Nijhawan
CIK: 0001777962
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
Edesa Biotech, Inc.
Discretionary Trading P&L
Holdings
Transaction History (42 total)
- Oct 28, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct27.6K shares- - Oct 5, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct6.9K shares- - Sep 1, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct5.7K shares- - Aug 3, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct5.3K shares- - Jul 2, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct3.4K shares- - Jun 16, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct153.6K shares at avg. $5.21$800K - Jun 1, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct1.7K shares- - May 27, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct96.9K shares- - May 1, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct1.2K shares- - Apr 1, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct2.6K shares- - Mar 10, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Direct1K shares at avg. $6.60$7K - Mar 5, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Indirect10K shares at avg. $3.90$39K - Mar 4, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Indirect10K shares at avg. $4.26$43K - Mar 3, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Indirect10K shares at avg. $3.63$36K - Mar 2, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Indirect1K shares at avg. $2.28$2K - Mar 2, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Direct2K shares at avg. $2.00$4K - Mar 2, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct10K shares- - Feb 27, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Indirect30K shares at avg. $2.22$67K - Feb 26, 2026EDSA
Edesa Biotech, Inc.
Purchase(P)Direct20.6K shares at avg. $1.58$32K - Feb 19, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct82.2K shares- - Feb 2, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct11.2K shares- - Jan 5, 2026EDSA
Edesa Biotech, Inc.
Award(A)Direct10.4K shares- - Dec 1, 2025EDSA
Edesa Biotech, Inc.
Award(A)Direct8.8K shares- - Nov 3, 2025EDSA
Edesa Biotech, Inc.
Award(A)Direct7K shares- - Oct 2, 2025EDSA
Edesa Biotech, Inc.
Award(A)Direct5.9K shares-
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 28, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 27,602 | - | $0 | Direct |
| Oct 5, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 6,893 | - | $0 | Direct |
| Sep 1, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 5,714 | - | $0 | Direct |
| Aug 3, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 5,324 | - | $0 | Direct |
| Jul 2, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 3,378 | - | $0 | Direct |
| Jun 16, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 153,550 | $5.21 | $799,996 | Direct |
| Jun 1, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 1,671 | - | $0 | Direct |
| May 27, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 96,913 | - | $0 | Direct |
| May 1, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 1,159 | - | $0 | Direct |
| Apr 1, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 2,578 | - | $0 | Direct |
| Mar 10, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 1,000 | $6.60 | $6,599 | Direct |
| Mar 5, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 10,000 | $3.90 | $39,000 | Indirect |
| Mar 4, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 10,000 | $4.26 | $42,560 | Indirect |
| Mar 3, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 10,000 | $3.63 | $36,300 | Indirect |
| Mar 2, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 1,000 | $2.28 | $2,280 | Indirect |
| Mar 2, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 2,000 | $2.00 | $4,000 | Direct |
| Mar 2, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 10,016 | - | $0 | Direct |
| Feb 27, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 30,000 | $2.22 | $66,696 | Indirect |
| Feb 26, 2026 | EDSA Edesa Biotech, Inc. | Purchase(P) | 20,571 | $1.58 | $32,480 | Direct |
| Feb 19, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 82,236 | - | $0 | Direct |
| Feb 2, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 11,168 | - | $0 | Direct |
| Jan 5, 2026 | EDSA Edesa Biotech, Inc. | Award(A) | 10,444 | - | $0 | Direct |
| Dec 1, 2025 | EDSA Edesa Biotech, Inc. | Award(A) | 8,766 | - | - | Direct |
| Nov 3, 2025 | EDSA Edesa Biotech, Inc. | Award(A) | 6,968 | - | - | Direct |
| Oct 2, 2025 | EDSA Edesa Biotech, Inc. | Award(A) | 5,908 | - | - | Direct |
1-25 of 42 transactions
About Nijhawan Pardeep
Nijhawan Pardeep (SEC CIK 0001777962) files insider reports with the SEC as Chief Executive Officer of Edesa Biotech, Inc. (EDSA).
Signal8 holds 37 ownership filings by Nijhawan Pardeep, all Form 4s, filed between Sep 3, 2024 and Oct 29, 2026. Those filings report 42 transactions, from Sep 3, 2024 to Oct 28, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Nijhawan Pardeep's filings is in TORONTO.
Recent filings by Nijhawan Pardeep
- Oct 28, 2026: Grant or award of EDSA shares (Form 4, code A).
- Oct 5, 2026: Grant or award of EDSA shares (Form 4, code A).
- Sep 1, 2026: Grant or award of EDSA shares (Form 4, code A).
- Aug 3, 2026: Grant or award of EDSA shares (Form 4, code A).
- Jul 2, 2026: Grant or award of EDSA shares (Form 4, code A).
Other insiders filing for Edesa Biotech, Inc. (EDSA)
- Marshall Patrick, Director
- MacDonald Sean Arthur, Director
- Chypyha Joan, Director
- Weiler Peter J., Chief Financial Officer
- Brooks Michael J, President
- Sistilli Carlo, Director